Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 4 minute read General business news PTC Therapeutics, TG Therapeutics, and Zimmer Biomet among top U.S. stock losers See which U.S. stocks fell the most on May 5, 2025, and why—an in-depth look at the market’s biggest losers amid trade tensions and sector-specific headwinds. byPallavi MadhirajuMay 6, 2025